XK and viral infectious disease: Since treatment with NA inhibitors have little antiviral effects against the low pathogenic and highly pathogenic human H7N9 viruses in mice [1,2], baloxavir marboxil would likely be the first choice to treat patients suffering from a H7N9 virus infection in the clinical setting.